Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Man (FIM) Study of the LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation

NCT07455539 is registered in ClinicalTrials.gov with Prince of Wales Hospital, Shatin, Hong Kong as lead sponsor.

NCT NCT07455539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Man (FIM) Study of the LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation
Lead sponsor
Prince of Wales Hospital, Shatin, Hong Kong
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 5, 2026
Completion date
May 1, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non valvular atrial fibrillation